Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dyslipidemias | 3 | 2012 | 256 | 0.750 |
Why?
|
| Coronary Disease | 3 | 2016 | 624 | 0.620 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2016 | 744 | 0.540 |
Why?
|
| Nasopharyngitis | 1 | 2016 | 6 | 0.500 |
Why?
|
| Pruritus | 1 | 2016 | 52 | 0.480 |
Why?
|
| Hypercholesterolemia | 1 | 2016 | 230 | 0.410 |
Why?
|
| Anticholesteremic Agents | 1 | 2016 | 239 | 0.410 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 298 | 0.390 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 342 | 0.350 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 981 | 0.320 |
Why?
|
| Influenza, Human | 1 | 2016 | 712 | 0.310 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 604 | 0.290 |
Why?
|
| Lipids | 2 | 2014 | 569 | 0.260 |
Why?
|
| C-Reactive Protein | 1 | 2010 | 450 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 1459 | 0.180 |
Why?
|
| Angina, Unstable | 1 | 2016 | 50 | 0.120 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2016 | 83 | 0.120 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2016 | 80 | 0.120 |
Why?
|
| Back Pain | 1 | 2016 | 30 | 0.120 |
Why?
|
| Ezetimibe | 1 | 2016 | 93 | 0.120 |
Why?
|
| Comorbidity | 2 | 2016 | 1595 | 0.100 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2014 | 91 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 2121 | 0.100 |
Why?
|
| Athletes | 1 | 2014 | 77 | 0.100 |
Why?
|
| Acute Coronary Syndrome | 1 | 2016 | 235 | 0.100 |
Why?
|
| Carotid Artery Diseases | 1 | 2014 | 130 | 0.100 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2016 | 570 | 0.090 |
Why?
|
| Medical Records | 1 | 2012 | 174 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 1295 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1267 | 0.090 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 383 | 0.080 |
Why?
|
| Nutrition Surveys | 1 | 2012 | 338 | 0.080 |
Why?
|
| Triglycerides | 1 | 2012 | 602 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2012 | 387 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 999 | 0.070 |
Why?
|
| Stroke | 1 | 2016 | 1061 | 0.070 |
Why?
|
| Aged | 3 | 2016 | 21025 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 887 | 0.060 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2006 | 10 | 0.060 |
Why?
|
| Acute Disease | 1 | 2010 | 1153 | 0.060 |
Why?
|
| Middle Aged | 3 | 2016 | 28601 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 645 | 0.060 |
Why?
|
| Recurrence | 1 | 2010 | 1489 | 0.060 |
Why?
|
| Prevalence | 1 | 2012 | 2701 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2010 | 1246 | 0.060 |
Why?
|
| Hypolipidemic Agents | 1 | 2006 | 202 | 0.050 |
Why?
|
| Biomarkers | 2 | 2014 | 3385 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3829 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 1173 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2012 | 3711 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 1129 | 0.040 |
Why?
|
| Humans | 5 | 2016 | 131163 | 0.040 |
Why?
|
| United States | 2 | 2014 | 12072 | 0.040 |
Why?
|
| Retirement | 1 | 2014 | 18 | 0.030 |
Why?
|
| Multidetector Computed Tomography | 1 | 2014 | 33 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2012 | 17753 | 0.030 |
Why?
|
| Football | 1 | 2014 | 39 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2010 | 12936 | 0.030 |
Why?
|
| Anthropometry | 1 | 2014 | 187 | 0.030 |
Why?
|
| Calcinosis | 1 | 2014 | 180 | 0.020 |
Why?
|
| Risk Factors | 1 | 2006 | 11074 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2014 | 450 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2014 | 369 | 0.020 |
Why?
|
| Male | 2 | 2014 | 64957 | 0.020 |
Why?
|
| Calcium | 1 | 2014 | 1010 | 0.020 |
Why?
|
| Smoking | 1 | 2014 | 932 | 0.020 |
Why?
|
| Mass Screening | 1 | 2014 | 822 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 1489 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 889 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 3061 | 0.010 |
Why?
|
| Female | 1 | 2012 | 70963 | 0.010 |
Why?
|